Meet-the-Professor Session:
190. Emergency Use Clinical Trials for Emerging Infectious Diseases
Saturday, October 29, 2016: 7:00 AM-8:15 AM
Room: 291-292

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe issues related to the design and implementation of Emergency Use clinical trials for emerging infectious diseases in the United States and internationally
  • discuss conventional principals of Common Rule such as ethical design, informed consent, patient safety monitoring and regulatory reporting for emergency use clinical trials, and how they relate to emergency use clinical trials in U.S and international trials
  • outline¬†critical elements necessary to allow emergency use clinical trial data to support FDA NDA/BLA decisions based on Animal Rule approval

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Members-in-training, Pharmacists, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Global ID, Pediatric ID, Investigative ID

Presentations:
7:00 AM
7:30 AM
8:00 AM
Q&A

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours 0.125 of pharmacy CE

ACPE Number: 0221-9999-16-277-L04-P


Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.